HWAM
IRWD icon

Hennion & Walsh Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Hennion & Walsh Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-184,485
Closed -$648K – 984
2026
Q1 		$648K Sell
184,485
-11,547
-6% -$47.3K 0.02% 632
2025
Q4 		$661K Buy
196,032
+26,539
+16% +$68.9K 0.02% 631
2025
Q3 		$222K Sell
169,493
-3,086
-2% -$3.19K 0.01% 903
2025
Q2 		$124K Sell
172,579
-7,973
-4% -$6.26K 0.01% 905
2025
Q1 		$265K Sell
180,552
-7,221
-4% -$17.2K 0.01% 784
2024
Q4 		$832K Buy
187,773
+16,962
+10% +$68.8K 0.04% 508
2024
Q3 		$704K Buy
170,811
+41,162
+32% +$221K 0.03% 533
2024
Q2 		$845K Buy
129,649
+118,462
+1,059% +$838K 0.04% 466
2024
Q1 		$97.4K Sell
11,187
-87
-0.8% -$1.06K 0.01% 834
2023
Q4 		$129K Sell
11,274
-242
-2% -$2.39K 0.01% 802
2023
Q3 		$111K Sell
11,516
-210
-2% -$2.06K 0.01% 781
2023
Q2 		$125K Buy
+11,726
New +$126K 0.01% 778
2022
Q4 		– Sell
-13,326
Closed -$138K – 785
2022
Q3 		$138K Sell
13,326
-482
-3% -$5.46K 0.01% 740
2022
Q2 		$159K Sell
13,808
-391
-3% -$4.61K 0.01% 738
2022
Q1 		$179K Sell
14,199
-836
-6% -$9.58K 0.01% 749
2021
Q4 		$175K Buy
+15,035
New +$184K 0.01% 727
2021
Q3 		– Sell
-17,294
Closed -$223K – 735
2021
Q2 		$223K Buy
17,294
+4,411
+34% +$50.5K 0.01% 688
2021
Q1 		$144K Buy
+12,883
New +$136K 0.01% 683

Other funds holding IRWD

WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
RFG
Range Financial Group Tigard, Oregon $366M AUM 76.17% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Hennion & Walsh Asset Management's IRWD Position: Q2 2026 in Review

Hennion & Walsh Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2026, closing a stake of 184,485 shares — an estimated $648K sold.

Hennion & Walsh Asset Management first reported a position in IRWD in Q1 2021 and held it in 18 quarters. The position peaked at $845K in Q2 2024. 14 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Hennion & Walsh Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 184,485 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $648K.
  • Hennion & Walsh Asset Management first reported a position in Ironwood Pharmaceuticals in Q1 2021 and held it in 18 quarters.
  • Hennion & Walsh Asset Management's Ironwood Pharmaceuticals position peaked at $845K in Q2 2024.
  • 14 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.